Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
The Lancet. Infectious Diseases|January 13, 2024
Efficacy and safety of fexinidazole for treatment of chronic indeterminate Chagas disease (FEXI-12): a multicentre, randomised, double-blind, phase 2 trialMaria-Jesus Pinazo, Colin Forsyth, Irene Losada, et al.
Parasites & Vectors|March 16, 2024
Onchocerca volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and LiberiaEric M Kanza, Amos Nyathirombo, Jemmah P Larbelee, et al.
Lancet (London, England)|January 24, 2018
Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trialNicholas O Opoku, Didier K Bakajika, Eric M Kanza, et al.
Frontiers in Aging Neuroscience|November 14, 2018
The Luxembourg Parkinson's Study: A Comprehensive Approach for Stratification and Early DiagnosisGeraldine Hipp, Michel Vaillant, Nico J Diederich, et al.
Cell Reports. Medicine|April 28, 2022
Combinatorial analysis reveals highly coordinated early-stage immune reactions that predict later antiviral immunity in mild COVID-19 patientsChristophe M Capelle, Séverine Ciré, Olivia Domingues, et al.
BMJ Open|September 30, 2025
New regimens of benznidazole for the treatment of chronic Chagas disease in adult participants in indeterminate form or with mild cardiac progression (NuestroBen study): protocol for a phase III randomised, multicentre non-inferiority clinical trialTayná Marques, Colin Forsyth, Fabiana Barreira, et al.
Frontiers in Neurology|January 4, 2024
Luxembourg Parkinson's study -comprehensive baseline analysis of Parkinson's disease and atypical parkinsonismLukas Pavelka, Rajesh Rawal, Soumyabrata Ghosh, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 11, 2024
Learning from post-COVID-19 condition for epidemic preparedness: a variable catalogue for future post-acute infection syndromesAnna Górska, Lorenzo Maria Canziani, Eugenia Rinaldi, et al.
Heliyon|May 23, 2024
Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptomsBarbara Wanjiru Citarella, Christiana Kartsonaki, Elsa D Ibáñez-Prada, et al.
BMC Infectious Diseases|February 9, 2024
Creation of a pandemic memory by tracing COVID-19 infections and immunity in Luxembourg (CON-VINCE)Olena Tsurkalenko, Dmitry Bulaev, Marc Paul O'Sullivan, et al.
Pageof 11